AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • October 9th, 2020 • Vivos Therapeutics, Inc. • Surgical & medical instruments & apparatus • Colorado
This AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of the 9th day of October, 2020 (the “Effective Date”) by and between VIVOS THERAPEUTICS, INC., a Delaware corporation having its principal place of business at 9137 S. Ridgeline Blvd., Suite 135, Highlands Ranch, Colorado 80129 (the “Company”) and DR. GURDEV DAVE SINGH, an individual currently residing in Sandia Park, New Mexico (the “Executive”). As used herein, the term “Parties” shall be used to refer to the Company and Executive jointly.
INTELLECTUAL PROPERTY & ASSET PURCHASE AGREEMENTIntellectual Property & Asset Purchase Agreement • October 9th, 2020 • Vivos Therapeutics, Inc. • Surgical & medical instruments & apparatus • Colorado
This INTELLECTUAL PROPERTY & ASSET PURCHASE AGREEMENT (the “Agreement”) is made and entered into as of the 4th day of May 2017 (the “Effective Date”) by and between VIVOS BIOTECHNOLOGIES, INC. (the “Buyer”), a Wyoming corporation and Dr. Gurdev Dave Singh (the “Seller”).
SHARE EXCHANGE AGREEMENT by and among: CORRECTIVE BIOTECHNOLOGIES, INC. a Wyoming Corporation andShare Exchange Agreement • October 9th, 2020 • Vivos Therapeutics, Inc. • Surgical & medical instruments & apparatus • Wyoming
This SHARE EXCHANGE AGREEMENT (the “Agreement”) is entered into as of August 10, 2016, by and among CORRECTIVE BIOTECHNOLOGIES, INC., a Wyoming corporation (“Corrective Biotechnologies”), with offices at 605 W. Knox Rd., Suite 202 Tempe, AZ 85284, BIOMODELING SOLUTIONS, INC., an Oregon corporation with offices located at 17933 NW Evergreen Pkwy., Suite 280 Beaverton, OR 97006 (“BioModeling”) the BioModeling shareholders listed on the signature page hereto (the “BioModeling Shareholders”), FIRST VIVOS, INC., a Texas corporation with offices at 514 Country Lane, Coppell, TX 75019 (“Vivos”) and the Vivos shareholders listed on the signature page hereto (the “Vivos Shareholders”), upon the following premises (BioModeling and Vivos are collectively referred to hereinafter as the “Acquired Companies”):
SECURITY AGREEMENTSecurity Agreement • October 9th, 2020 • Vivos Therapeutics, Inc. • Surgical & medical instruments & apparatus
This SECURITY AGREEMENT (the “Agreement”) is made and entered into as of the 6th day of May, 2017 (the “Effective Date”) by and between VIVOS BIOTECHNOLOGIES, INC. (the “Buyer”), a Wyoming corporation and Dr. Gurdev Dave Singh (the “Seller”).
AMENDMENT TO SHARE EXCHANGE AGREEMENTShare Exchange Agreement • October 9th, 2020 • Vivos Therapeutics, Inc. • Surgical & medical instruments & apparatus
THIS AMENDMENT TO SHARE EXCHANGE AGREEMENT (the “Amendment”) is made effective as of September 15, 2016 by and among VIVOS BIOTECHNOLOGIES, INC. (formerly, Corrective Biotechnologies, Inc.), a Wyoming corporation with offices located at 605 W. Know Road, Suite 202, Tempe, Arizona 85284, (“Vivos Biotechnologies”), BIOMODELING SOLUTIONS, INC., an Oregon corporation with offices located at 17933 NW Evergreen Pkwy., Suite 28, Beaverton, OR 97006 (“BioModeling”), the BioModeling shareholders who have consented to this Amendment (the “BioModeling Shareholders”), FIRST VIVOS, INC., a Texas corporation with offices at 514 Country Lane, Coppell, TX 75019 and the Vivos shareholders who have consented to this Amendment (the “Vivos Shareholders”). Vivos Biotechnologies, BioModeling, the BioModeling Shareholders, Vivos and the Vivos Shareholders may collectively be referred to as the “Parties”.
